114 related articles for article (PubMed ID: 8749850)
1. Control of crystal forms of apoferritin by site-directed mutagenesis.
Takeda S; Yoshimura H; Endo S; Takahashi T; Nagayama K
Proteins; 1995 Dec; 23(4):548-56. PubMed ID: 8749850
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of haemin demetallation by L-chain apoferritins.
de Val N; Declercq JP; Lim CK; Crichton RR
J Inorg Biochem; 2012 Jul; 112():77-84. PubMed ID: 22561545
[TBL] [Abstract][Full Text] [Related]
3. EPR studies of recombinant horse L-chain apoferritin and its mutant (E 53,56,57,60 Q) with haemin.
de Val N; Hagen WR; Crichton RR
Biometals; 2007 Feb; 20(1):21-6. PubMed ID: 16988881
[TBL] [Abstract][Full Text] [Related]
4. Evidence of new cadmium binding sites in recombinant horse L-chain ferritin by anomalous Fourier difference map calculation.
Granier T; Comberton G; Gallois B; d'Estaintot BL; Dautant A; Crichton RR; Précigoux G
Proteins; 1998 Jun; 31(4):477-85. PubMed ID: 9626706
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis.
Choi HK; Lee S; Zhang YP; McKinney BR; Wengler G; Rossmann MG; Kuhn RJ
J Mol Biol; 1996 Sep; 262(2):151-67. PubMed ID: 8831786
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-terminal residues on the structural stability of recombinant horse L-chain apoferritin in an acidic environment.
Yoshizawa K; Mishima Y; Park SY; Heddle JG; Tame JR; Iwahori K; Kobayashi M; Yamashita I
J Biochem; 2007 Dec; 142(6):707-13. PubMed ID: 17938140
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of nickel and chromium nanoparticles using the protein cage of apoferritin.
Okuda M; Iwahori K; Yamashita I; Yoshimura H
Biotechnol Bioeng; 2003 Oct; 84(2):187-94. PubMed ID: 12966575
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional crystals of apoferritin.
Yoshimura H
Adv Biophys; 1997; 34():93-107. PubMed ID: 9204129
[TBL] [Abstract][Full Text] [Related]
9. The Cfr10I restriction enzyme is functional as a tetramer.
Siksnys V; Skirgaila R; Sasnauskas G; Urbanke C; Cherny D; Grazulis S; Huber R
J Mol Biol; 1999 Sep; 291(5):1105-18. PubMed ID: 10518946
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the thermostable arginine repressor from Bacillus stearothermophilus: dissecting residues involved in DNA binding properties.
Karaivanova IM; Weigel P; Takahashi M; Fort C; Versavaud A; Van Duyne G; Charlier D; Hallet JN; Glansdorff N; Sakanyan V
J Mol Biol; 1999 Aug; 291(4):843-55. PubMed ID: 10452892
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of Y34F mutant human mitochondrial manganese superoxide dismutase and the functional role of tyrosine 34.
Guan Y; Hickey MJ; Borgstahl GE; Hallewell RA; Lepock JR; O'Connor D; Hsieh Y; Nick HS; Silverman DN; Tainer JA
Biochemistry; 1998 Apr; 37(14):4722-30. PubMed ID: 9537987
[TBL] [Abstract][Full Text] [Related]
12. Molecular-level thermodynamic and kinetic parameters for the self-assembly of apoferritin molecules into crystals.
Yau ST; Petsev DN; Thomas BR; Vekilov PG
J Mol Biol; 2000 Nov; 303(5):667-78. PubMed ID: 11061967
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the structures of the cubic and tetragonal forms of horse-spleen apoferritin.
Granier T; Gallois B; Dautant A; Langlois d'Estaintot B; Précigoux G
Acta Crystallogr D Biol Crystallogr; 1997 Sep; 53(Pt 5):580-7. PubMed ID: 15299889
[TBL] [Abstract][Full Text] [Related]
14. Optical and EPR spectroscopic studies of demetallation of hemin by L-chain apoferritins.
Carette N; Hagen W; Bertrand L; de Val N; Vertommen D; Roland F; Hue L; Crichton RR
J Inorg Biochem; 2006 Aug; 100(8):1426-35. PubMed ID: 16781777
[TBL] [Abstract][Full Text] [Related]
15. High resolution crystal structures of amphibian red-cell L ferritin: potential roles for structural plasticity and solvation in function.
Trikha J; Theil EC; Allewell NM
J Mol Biol; 1995 May; 248(5):949-67. PubMed ID: 7760335
[TBL] [Abstract][Full Text] [Related]
16. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
[TBL] [Abstract][Full Text] [Related]
17. The 2.15 A crystal structure of a triple mutant plastocyanin from the cyanobacterium Synechocystis sp. PCC 6803.
Romero A; De la Cerda B; Varela PF; Navarro JA; Hervás M; De la Rosa MA
J Mol Biol; 1998 Jan; 275(2):327-36. PubMed ID: 9466912
[TBL] [Abstract][Full Text] [Related]
18. Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica.
Gawlak SL; Neubauer M; Klei HE; Chang CY; Einspahr HM; Siegall CB
Biochemistry; 1997 Mar; 36(11):3095-103. PubMed ID: 9115985
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisited.
Ferraroni M; Rypniewski W; Wilson KS; Viezzoli MS; Banci L; Bertini I; Mangani S
J Mol Biol; 1999 May; 288(3):413-26. PubMed ID: 10329151
[TBL] [Abstract][Full Text] [Related]
20. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
del Camino D; Barros F; Pardo LA; de la Peña P
Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
